View in EDS HTML Full Text PDF Full Text

Acceptability and tolerability of repeated intramuscular electroporation of Multi-antigenic HIV (HIVMAG) DNA vaccine among healthy African participants in a phase 1 randomized controlled trial.

Saved in:
Bibliographic Details
Title: Acceptability and tolerability of repeated intramuscular electroporation of Multi-antigenic HIV (HIVMAG) DNA vaccine among healthy African participants in a phase 1 randomized controlled trial.
Authors: Mpendo J; Uganda Virus Research Institute-International AIDS Vaccine Initiative, HIV Vaccine Program, Entebbe, Uganda., Mutua G; Kenya AIDS Vaccine Initiative, University of Nairobi, Nairobi, Kenya., Nanvubya A; Uganda Virus Research Institute-International AIDS Vaccine Initiative, HIV Vaccine Program, Entebbe, Uganda., Anzala O; Kenya AIDS Vaccine Initiative, University of Nairobi, Nairobi, Kenya., Nyombayire J; Project San Francisco (PSF), Kigali, Rwanda., Karita E; Project San Francisco (PSF), Kigali, Rwanda., Dally L; EMMES Corporation, Rockville, Maryland, United States of America., Hannaman D; Ichor Medical Systems, Inc., San Diego, California, United States of America., Price M; International AIDS Vaccine Initiative (IAVI), New York, NY, United States of America., Fast PE; International AIDS Vaccine Initiative (IAVI), New York, NY, United States of America., Priddy F; International AIDS Vaccine Initiative (IAVI), New York, NY, United States of America., Gelderblom HC; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America., Hills NK; University of California at San Francisco, San Francisco, California, United States of America.
Source: PloS one [PLoS One] 2020 May 29; Vol. 15 (5), pp. e0233151. Date of Electronic Publication: 2020 May 29 (Print Publication: 2020).
Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 32469893
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Acceptability and tolerability of repeated intramuscular electroporation of Multi-antigenic HIV (HIVMAG) DNA vaccine among healthy African participants in a phase 1 randomized controlled trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Mpendo+J%22">Mpendo J</searchLink>; Uganda Virus Research Institute-International AIDS Vaccine Initiative, HIV Vaccine Program, Entebbe, Uganda.<br /><searchLink fieldCode="AU" term="%22Mutua+G%22">Mutua G</searchLink>; Kenya AIDS Vaccine Initiative, University of Nairobi, Nairobi, Kenya.<br /><searchLink fieldCode="AU" term="%22Nanvubya+A%22">Nanvubya A</searchLink>; Uganda Virus Research Institute-International AIDS Vaccine Initiative, HIV Vaccine Program, Entebbe, Uganda.<br /><searchLink fieldCode="AU" term="%22Anzala+O%22">Anzala O</searchLink>; Kenya AIDS Vaccine Initiative, University of Nairobi, Nairobi, Kenya.<br /><searchLink fieldCode="AU" term="%22Nyombayire+J%22">Nyombayire J</searchLink>; Project San Francisco (PSF), Kigali, Rwanda.<br /><searchLink fieldCode="AU" term="%22Karita+E%22">Karita E</searchLink>; Project San Francisco (PSF), Kigali, Rwanda.<br /><searchLink fieldCode="AU" term="%22Dally+L%22">Dally L</searchLink>; EMMES Corporation, Rockville, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Hannaman+D%22">Hannaman D</searchLink>; Ichor Medical Systems, Inc., San Diego, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Price+M%22">Price M</searchLink>; International AIDS Vaccine Initiative (IAVI), New York, NY, United States of America.<br /><searchLink fieldCode="AU" term="%22Fast+PE%22">Fast PE</searchLink>; International AIDS Vaccine Initiative (IAVI), New York, NY, United States of America.<br /><searchLink fieldCode="AU" term="%22Priddy+F%22">Priddy F</searchLink>; International AIDS Vaccine Initiative (IAVI), New York, NY, United States of America.<br /><searchLink fieldCode="AU" term="%22Gelderblom+HC%22">Gelderblom HC</searchLink>; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America.<br /><searchLink fieldCode="AU" term="%22Hills+NK%22">Hills NK</searchLink>; University of California at San Francisco, San Francisco, California, United States of America.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101285081%22">PloS one</searchLink> [PLoS One] 2020 May 29; Vol. 15 (5), pp. e0233151. <i>Date of Electronic Publication: </i>2020 May 29 (<i>Print Publication: </i>2020).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase I; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Public+Library+of+Science%22">Public Library of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101285081 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1932-6203 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219326203%22">19326203 </searchLink><i>NLM ISO Abbreviation: </i>PLoS One <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32469893
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1371/journal.pone.0233151
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e0233151
    Titles:
      – TitleFull: Acceptability and tolerability of repeated intramuscular electroporation of Multi-antigenic HIV (HIVMAG) DNA vaccine among healthy African participants in a phase 1 randomized controlled trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Mpendo J
      – PersonEntity:
          Name:
            NameFull: Mutua G
      – PersonEntity:
          Name:
            NameFull: Nanvubya A
      – PersonEntity:
          Name:
            NameFull: Anzala O
      – PersonEntity:
          Name:
            NameFull: Nyombayire J
      – PersonEntity:
          Name:
            NameFull: Karita E
      – PersonEntity:
          Name:
            NameFull: Dally L
      – PersonEntity:
          Name:
            NameFull: Hannaman D
      – PersonEntity:
          Name:
            NameFull: Price M
      – PersonEntity:
          Name:
            NameFull: Fast PE
      – PersonEntity:
          Name:
            NameFull: Priddy F
      – PersonEntity:
          Name:
            NameFull: Gelderblom HC
      – PersonEntity:
          Name:
            NameFull: Hills NK
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 29
              M: 05
              Text: 2020 May 29
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-electronic
              Value: 1932-6203
          Numbering:
            – Type: volume
              Value: 15
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: PloS one
              Type: main
ResultId 1